Thomas A. Mccourt
Chief Executive Officer at Ironwood Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ironwood Pharmaceuticals Inc., 3 years.
Ironwood Pharmaceuticals Inc.
Director · Chief Executive Officer
Pliant Therapeutics Inc.
Director
Chief executive roles
Ironwood Pharmaceuticals Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +409,836 | — | — |
| Feb 24, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −103,526 | $3.66 | $378,905 |
| Feb 23, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −94,757 | $3.81 | $361,024 |
| May 20, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +540,000 | — | — |
| May 16, 2025 | Ironwood Pharmaceuticals Inc. | Open-market sale | −13,353 | $0.58 | $7,745 |
| Feb 10, 2025 | Ironwood Pharmaceuticals Inc. | Open-market sale | −139,064 | $1.76 | $244,753 |
| Jan 17, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +147,354 | — | — |
| May 20, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −67,618 | $6.45 | $436,136 |
| Mar 8, 2024 | Ironwood Pharmaceuticals Inc. | Option exercise | +120,298 | — | — |
| Mar 5, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +264,876 | — | — |
| Feb 12, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −177,164 | $15.24 | $2,699,979 |
| Jan 17, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +249,617 | — | — |
| May 30, 2023 | Ironwood Pharmaceuticals Inc. | Open-market sale | −26,632 | $10.70 | $284,962 |
| May 22, 2023 | Ironwood Pharmaceuticals Inc. | Open-market sale | −36,000 | $10.12 | $364,320 |
| May 8, 2023 | Ironwood Pharmaceuticals Inc. | Open-market sale | −21,148 | $10.62 | $224,592 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.